Want to see SE:AINO full AI Analyst Report?

Aino Health AB (AINO) Price & Analysis

0 Followers

AINO Stock Chart & Stats

kr0.18

-kr0.04(-22.87%)

At close: Mar 06 4:00 PM EST

kr0.18

-kr0.04(-22.87%)

Day’s Range― - ―

52-Week Rangekr0.11 - kr0.29

Previous CloseN/A

Volume5.00K

Average Volume (3M)37.35K

Market Cap

kr40.30M

Enterprise Valuekr45.75

Total Cash (Recent Filing)kr1.92M

Total Debt (Recent Filing)kr7.98M

Price to Earnings (P/E)―

Beta1.31

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.05

Shares Outstanding204,569,100

10 Day Avg. Volume57,458

30 Day Avg. Volume37,353

Financial Highlights & Ratios

PEG Ratio0.10

Price to Book (P/B)-5.45

Price to Sales (P/S)1.34

P/FCF Ratio-14.49

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Occupational Health Software FocusThe company addresses a persistent employer need: managing employee well-being and sickness absence. A focused digital workflow can support repeat organizational use if Aino converts its offering into scalable, durable customer relationships.

Losses Have Narrowed From Prior LevelsAlthough profitability remains deeply negative, the improvement from 2022 indicates some progress in reducing losses. Sustaining this direction could improve operating leverage and strengthen the path toward eventual break-even.

Cash Burn Improved Versus 2022Operating cash consumption is still substantial, but the reduction from 2022 shows that cash control has improved over the longer period. Further improvement would reduce dependence on external funding and support business continuity.

Bears Say

Persistent Unprofitability And Declining RevenueRevenue contraction combined with deeply negative operating and net margins signals that the business has not yet achieved a sustainable economic model. Continued losses can restrict investment, weaken scale benefits, and delay self-funded growth.

Negative Equity And Thin Capital BaseNegative equity and debt exceeding assets materially reduce financial resilience. The capital deficit raises refinancing and funding risk, limits strategic flexibility, and leaves the company more exposed if operating losses continue.

Ongoing And Volatile Cash ConsumptionPersistent negative cash flow means operations are not currently self-funding, while the deterioration from 2025 shows inconsistent progress. Continued cash use may require external capital, increasing dilution or refinancing pressure.

AINO FAQ

What was Aino Health AB’s price range in the past 12 months?

Aino Health AB lowest stock price was kr0.11 and its highest was kr0.29 in the past 12 months.

What is Aino Health AB’s market cap?

Aino Health AB’s market cap is kr40.30M.

When is Aino Health AB’s upcoming earnings report date?

Aino Health AB’s upcoming earnings report date is Nov 12, 2026 which is in 79 days.

How were Aino Health AB’s earnings last quarter?

Aino Health AB released its earnings results on Aug 17, 2026. The company reported -kr0.013 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Aino Health AB overvalued?

According to Wall Street analysts Aino Health AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aino Health AB pay dividends?

Aino Health AB does not currently pay dividends.

What is Aino Health AB’s EPS estimate?

Aino Health AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aino Health AB have?

Aino Health AB has 204,569,100 shares outstanding.

What happened to Aino Health AB’s price movement after its last earnings report?

Aino Health AB reported an EPS of -kr0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Aino Health AB?

Currently, no hedge funds are holding shares in SE:AINO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aino Health AB

Aino Health AB (publ), a Swedish company based in Stockholm, specializes in delivering comprehensive corporate health management solutions to both private and public organizations throughout Finland. Their flagship offering is HealthManager, a Software-as-a-Service (SaaS) platform equipped with tools for health surveys, analytical insights, exposure checks, and compliance with security and GDPR regulations, along with an integrated e-learning module. Beyond the software, Aino Health provides a range of additional services, including telemedicine, professional support (such as analytics, management/employee guidance, and well-being programs), and onboarding assistance covering project management, implementation, and training. The company also extends its services to a diverse network of partners, including occupational health providers, insurance companies, IT firms, HR/payroll service centers, and various healthcare practitioners.